Skip to content

Clinical trials

Hepatitis C, Chronic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Country / region: Canada Clear all

77 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20042
20055
20065
20078
20084
20095
20106
201110
201211
20141
20153
20164
20176
20181
20191
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64
Terminated6
Unknown status4
Withdrawn2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche18
Gilead Sciences8
AbbVie7
Boehringer Ingelheim5
Human Genome Sciences Inc.4
BioWest Therapeutics Inc3
University Health Network, Toronto3
Vertex Pharmaceuticals Incorporated3
Debiopharm International SA2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic77
Hepatitis C32
Fibrosis4
Hepatitis4
Acquired Immunodeficiency Syndrome3
Hepatitis B2
Infections2
Virus Diseases2
Bone Diseases, Metabolic1
Bronchiolitis Obliterans Syndrome1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.